Silver Book Fact

Using medical imaging to diagnose and treat stroke leads to better outcomes and shorter hospital stays, which yields a net economic benefit of about $8 billion over 10 years.

Johnston, S. Claiborne, John Rootenberg, Sarosh Katrak, W.S. Smith, and Jacob Elkins. Effect of a U.S. National Institute of Health Programme of Clinical Trials in Public Health and Costs. The Lancet. April 22, 2006; 367: 1319-27. http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16631910&dopt=AbstractPlus

Reference

Title
Effect of a U.S. National Institute of Health Programme of Clinical Trials in Public Health and Costs
Publication
The Lancet
Publication Date
April 22, 2006
Authors
Johnston, S. Claiborne, John Rootenberg, Sarosh Katrak, W.S. Smith, and Jacob Elkins
Pages
1319-27
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Every additional dollar spent on the overall treatment of stroke has produced health gains valued at $1.55.  
  • The greater use of medications and revascularization would provide approximately a 17% reduction in 2 year mortality combined.  
  • Survival rates of patients ages 65-75 with valve repair and replacement
     
  • Cost of warfarin therapy for AFib patients
    In patients with nonvalvular atrial fibrillation (AF) and one additional stroke risk factor, warfarin therapy cost $8,000 per quality-adjusted life-year (QALY) saved.  
  • Use of antihypertensive therapies avoided an estimated $10.7 billion in 2002 direct medical costs as a result of fewer strokes. They also avoided an estimated $5.8 billion in 2002…